Vanguard Group’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$482M Buy
3,595,957
+20,961
+0.6% +$2.81M 0.01% 1048
2025
Q1
$241M Sell
3,574,996
-60,923
-2% -$4.1M ﹤0.01% 1396
2024
Q4
$227M Buy
3,635,919
+40,860
+1% +$2.55M ﹤0.01% 1489
2024
Q3
$564M Buy
3,595,059
+1,068,659
+42% +$168M 0.01% 965
2024
Q2
$381M Buy
2,526,400
+637,306
+34% +$96M 0.01% 1125
2024
Q1
$140M Buy
1,889,094
+23,979
+1% +$1.77M ﹤0.01% 1695
2023
Q4
$147M Buy
1,865,115
+50,673
+3% +$4M ﹤0.01% 1670
2023
Q3
$99.3M Buy
1,814,442
+29,798
+2% +$1.63M ﹤0.01% 1814
2023
Q2
$150M Buy
1,784,644
+66,388
+4% +$5.58M ﹤0.01% 1626
2023
Q1
$130M Buy
1,718,256
+26,831
+2% +$2.03M ﹤0.01% 1687
2022
Q4
$104M Buy
1,691,425
+46,734
+3% +$2.88M ﹤0.01% 1785
2022
Q3
$68.7M Buy
1,644,691
+208,377
+15% +$8.7M ﹤0.01% 2017
2022
Q2
$45.2M Buy
1,436,314
+109,408
+8% +$3.44M ﹤0.01% 2244
2022
Q1
$35.7M Sell
1,326,906
-3,613
-0.3% -$97.3K ﹤0.01% 2470
2021
Q4
$25.5M Buy
1,330,519
+68,288
+5% +$1.31M ﹤0.01% 2711
2021
Q3
$41.8M Buy
1,262,231
+33,453
+3% +$1.11M ﹤0.01% 2457
2021
Q2
$40.8M Buy
1,228,778
+15,783
+1% +$524K ﹤0.01% 2478
2021
Q1
$50.3M Buy
1,212,995
+54,528
+5% +$2.26M ﹤0.01% 2315
2020
Q4
$23.1M Buy
1,158,467
+31,540
+3% +$628K ﹤0.01% 2562
2020
Q3
$15.5M Buy
1,126,927
+260,899
+30% +$3.6M ﹤0.01% 2573
2020
Q2
$15.5M Buy
866,028
+193,645
+29% +$3.47M ﹤0.01% 2548
2020
Q1
$8.12M Buy
672,383
+18,103
+3% +$219K ﹤0.01% 2708
2019
Q4
$12.4M Buy
654,280
+301,818
+86% +$5.74M ﹤0.01% 2751
2019
Q3
$8.37M Buy
352,462
+43,503
+14% +$1.03M ﹤0.01% 2909
2019
Q2
$8.96M Buy
+308,959
New +$8.96M ﹤0.01% 2919